DIAGNOSIS AND TREATMENT HISTORY BEFORE PSORIASIS DIAGNOSIS AMONG PATIENTS WITH MODERATE-TO-SEVERE PSORIASIS

被引：0
|
作者：
Feldman, S. R. [1 ]
Zhao, Y. [2 ]
Hur, P. [2 ]
Liu, J. S. [3 ]
Herrera, V [2 ]
机构：
[1] Wake Forest Baptist Med Ctr, Winston Salem, NC USA
[2] Novartis Pharmaceut, E Hanover, NJ USA
[3] Harvard Univ, Cambridge, MA 02138 USA
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 05期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSS4
引用
收藏
页码：A156 / A156
页数：1
相关论文
共 50 条
  • [1] Tuscan consensus on the diagnosis, treatment and follow-up of moderate-to-severe psoriasis
    Prignano, Francesca
    Tripo, Lara
    Amato, Lauretta
    Bagnoni, Giovanni
    Bartoli, Laura
    Battistini, Silvio
    Bellini, Mauro
    Brandini, Luca
    Caproni, Marzia
    Cardinali, Carla
    Castelli, Antonio
    Cecchi, Roberto
    Cervadoro, Gregorio
    Dini, Valentina
    Fimiani, Michele
    Eberle, Olimpia
    Fabbri, Paolo
    Lo Scocco, Giovanni
    Martini, Patrizia
    Marsili, Franco
    Mazzatenta, Carlo
    Niccoli, Maria Chiara
    Peccianti, Camilla
    Pellegrino, Michele
    Romanelli, Marco
    Sirna, Riccardo
    Taviti, Franca
    Volpi, Valter
    Pimpinelli, Nicola
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2017, 152 (02): : 99 - 108
  • [2] Infliximab treatment improves productivity among patients with moderate-to-severe psoriasis
    Reich, Kristian
    Nestle, Frank O.
    Wu, Ying
    Bala, Mohan
    Eisenberg, Debra
    Guzzo, Cynthia
    Li, Shu
    Dooley, Lisa T.
    Griffiths, Christopher E. M.
    EUROPEAN JOURNAL OF DERMATOLOGY, 2007, 17 (05) : 381 - 386
  • [3] TREATMENT SATISFACTION AMONG PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS IN BRAZIL
    Lopes, N.
    Suarez, R. M.
    Sabbag, C. Y.
    Kobata, C. M.
    Takemoto, M. S.
    Pertel, P.
    VALUE IN HEALTH, 2017, 20 (09) : A902 - A902
  • [4] Tofacitinib for the treatment of moderate-to-severe psoriasis
    Chiricozzi, Andrea
    Faleri, Sara
    Saraceno, Rosita
    Bianchi, Luca
    Buonomo, Oreste
    Chimenti, Sergio
    Chimenti, Maria Sole
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (04) : 443 - 455
  • [5] Tailored biological treatment for patients with moderate-to-severe psoriasis
    Maurelli, Martina
    Gisondi, Paolo
    Girolomoni, Giampiero
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2023, 19 (01) : 37 - 43
  • [6] Treatment of moderate-to-severe plaque psoriasis
    Salgo, R.
    Thaci, D.
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2009, 144 (06): : 701 - 711
  • [7] Effectiveness of guselkumab among patients with moderate-to-severe plaque psoriasis in the Corrona Psoriasis Registry
    Armstrong, April W.
    Callis-Duffin, Kristina
    Fitzgerald, Timothy
    Teeple, Amanda
    Uy, Jonathan
    Olurinde, Mobolaji
    Rowland, Katelyn
    McLean, Robert R.
    Guo, Lin
    Shan, Ying
    Van Voorhees, Abby S.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB122 - AB122
  • [8] Economic and Comorbidity Burden Among Patients with Moderate-to-Severe Psoriasis
    Feldman, Steven R.
    Zhao, Yang
    Shi, Lizheng
    Tran, Mary Helen
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2015, 21 (10): : 874 - 888
  • [9] Ixekizumab versus FAEs and methotrexate in treatment of nail psoriasis in patients with moderate-to-severe psoriasis
    Augustin, Matthias
    Mrowietz, Ulrich
    Willsmann-Theis, Dagmar
    Gerdes, Sascha
    Fotiou, Konstantinos
    Schuster, Christopher
    Mert, Can
    Holzkaemper, Thorsten
    Behrens, Frank
    Pinter, Andreas
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2024,
  • [10] Pooled efficacy of infliximab for the treatment of patients with moderate-to-severe psoriasis
    Menter, A.
    Papp, K.
    Guzzo, C.
    Li, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 249 - 249
12345